These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22125989)

  • 1. Histopathological changes caused by doxorubicin in laboratory mice (Mus Musculus L).
    Abbas EK
    J Pak Med Assoc; 2011 Nov; 61(11):1108-10. PubMed ID: 22125989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity.
    Gokcimen A; Cim A; Tola HT; Bayram D; Kocak A; Ozgüner F; Ayata A
    Hum Exp Toxicol; 2007 Jun; 26(6):519-25. PubMed ID: 17698947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats.
    Yagmurca M; Bas O; Mollaoglu H; Sahin O; Nacar A; Karaman O; Songur A
    Arch Med Res; 2007 May; 38(4):380-5. PubMed ID: 17416283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine modulates doxorubicin-induced oxidative stress and antioxidant vitamin concentrations in liver of rats.
    Koçkar MC; Nazıroğlu M; Celik O; Tola HT; Bayram D; Koyu A
    Cell Biochem Funct; 2010 Dec; 28(8):673-7. PubMed ID: 21104935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model.
    Namur J; Wassef M; Millot JM; Lewis AL; Manfait M; Laurent A
    J Vasc Interv Radiol; 2010 Feb; 21(2):259-67. PubMed ID: 20123210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute dosage with dexrazoxane, but not doxorubicin, is associated with increased rates of hepatic protein synthesis in vivo.
    Zima T; Tesar V; Sherwood R; Sood A; Au LC; Richardson PJ; Preedy VR
    Toxicol Pathol; 2001; 29(6):591-9. PubMed ID: 11794374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity.
    Henninger C; Huelsenbeck J; Huelsenbeck S; Grösch S; Schad A; Lackner KJ; Kaina B; Fritz G
    Toxicol Appl Pharmacol; 2012 May; 261(1):66-73. PubMed ID: 22712078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-allylcysteine ameliorates doxorubicin toxicity in the heart and liver in mice.
    Mostafa MG; Mima T; Ohnishi ST; Mori K
    Planta Med; 2000 Mar; 66(2):148-51. PubMed ID: 10763589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoductules in the rat liver in experimental adriamycin-induced nephrotic syndrome.
    Pedrycz A; Wieczorski M; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):154-60. PubMed ID: 12898918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver.
    Patel N; Joseph C; Corcoran GB; Ray SD
    Toxicol Appl Pharmacol; 2010 Jun; 245(2):143-52. PubMed ID: 20144634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
    Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis.
    Di Stefano G; Fiume L; Domenicali M; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Pariali M; Bernardi M
    Dig Liver Dis; 2006 Jun; 38(6):404-8. PubMed ID: 16595196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal and liver changes after chronic ketamine and ketamine plus alcohol treatment.
    Wong YW; Lam LH; Tang HC; Liang Y; Tan S; Yew DT
    Microsc Res Tech; 2012 Sep; 75(9):1170-5. PubMed ID: 22623411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactosylated α,β-poly[(2-hydroxyethyl)-L-aspartamide]-bound doxorubicin: improved antitumor activity against hepatocellular carcinoma with reduced hepatotoxicity.
    Cheng X; Gao F; Xiang J; Jiang X; Chen J; Zhang J
    Anticancer Drugs; 2011 Feb; 22(2):136-47. PubMed ID: 20966743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal use of doxorubicin drug-eluting beads in sheep: a pilot safety study.
    Binder S; Lewis AL; Jesenofsky R; Neumaier M; Jäger E; Ströbel P; Löhr JM; Keese M
    Anticancer Res; 2012 Dec; 32(12):5167-74. PubMed ID: 23225413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicology and histopathology of some rodenticides and palatable food items combinations on the common mice Mus musculus var. albus in Egypt.
    Mesban HA; Tayeb EH; Mourad AK; Younis LK; el Zaher MA; Aly MT
    Commun Agric Appl Biol Sci; 2003; 68(4 Pt B):771-87. PubMed ID: 15151313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Means of evaluation and protection from doxorubicin-induced cardiotoxicity and hepatotoxicity in rats.
    Salouege I; Ben Ali R; Ben Saïd D; Elkadri N; Kourda N; Lakhal M; Klouz A
    J Cancer Res Ther; 2014; 10(2):274-8. PubMed ID: 25022377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of doxorubicin induced cardio-and hepato-toxicity by carotenoids.
    Indu R; Azhar TS; Nair A; Nair CK
    J Cancer Res Ther; 2014; 10(1):62-7. PubMed ID: 24762488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248).
    Mosure KW; Henderson AJ; Klunk LJ; Knipe JO
    Cancer Chemother Pharmacol; 1997; 40(3):251-8. PubMed ID: 9219510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice.
    Rocha VC; França LS; de Araújo CF; Ng AM; de Andrade CM; Andrade AC; Santos Ede S; Borges-Silva Mda C; Macambira SG; Noronha-Dutra AA; Pontes-de-Carvalho LC
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):659-62. PubMed ID: 26712129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.